Heron Therapeutics Inc. diskutieren
Heron Therapeutics Inc.
WKN: A1XB6K / Symbol: HRTX / Name: Heron Inc / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
1,22 €
-4,91 %
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its price target lowered by analysts at Needham & Company LLC from $8.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its price target lowered by analysts at Evercore ISI from $15.00 to $10.00. They now have an "outperform" rating on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $7.00 price target on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its price target lowered by analysts at Needham & Company LLC from $6.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its price target lowered by analysts at Needham & Company LLC from $5.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its price target raised by analysts at Needham & Company LLC from $4.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $6.00 price target on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $7.00 price target on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its price target lowered by analysts at Needham & Company LLC from $5.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
Ratings data for HRTX provided by MarketBeat
Heron Therapeutics, Inc. (NASDAQ: HRTX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for HRTX provided by MarketBeat
Der Beitrag wird untersucht
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
Ratings data for HRTX provided by MarketBeat
Neueste Beiträge
Raymond_James in Discuss GDS Holdings Ltd ADR